RAPT - RAPT Therapeutics Inc
58.02
0.040 0.069%
Share volume: 11,125,216
Last Updated: 03-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$57.98
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-06-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 32.518 M | 29.330 M | 19.788 M | 54.465 M | 19.265 M | 19.535 M | 19.371 M | |
| Selling general and admin | 7.737 M | 6.690 M | 6.448 M | 8.009 M | 7.223 M | 7.195 M | 7.337 M | |
| Research and development | 24.781 M | 22.640 M | 13.340 M | 46.456 M | 12.042 M | 12.340 M | 12.034 M | |
| Total expenses | 32.518 M | 29.330 M | 19.788 M | 54.465 M | 19.265 M | 19.535 M | 19.371 M | |
| -9.80% | -32.53% | 175.24% | -64.63% | 1.40% | -0.84% | |||
| Operating income | -32.518 M | -29.330 M | -19.788 M | -54.465 M | -19.265 M | -19.535 M | -19.371 M | |
| Ebit | -30.521 M | -27.663 M | -18.432 M | -53.249 M | -17.165 M | -17.643 M | -17.580 M | |
| Pretax income | -30.521 M | -27.663 M | -18.432 M | -53.249 M | -17.165 M | -17.643 M | -17.580 M | |
| -9.36% | -33.37% | 188.89% | -67.76% | 2.78% | -0.36% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -30.521 M | -27.663 M | -18.432 M | -53.249 M | -17.165 M | -17.643 M | -17.580 M | |
| 9.36% | 33.37% | -188.89% | 67.76% | -2.78% | 0.36% |